Transfer of a minimally invasive mitral valve repair program from a high-volume center to a very low volume center: how many cases are necessary to maintain acceptable results?


Journal

General thoracic and cardiovascular surgery
ISSN: 1863-6713
Titre abrégé: Gen Thorac Cardiovasc Surg
Pays: Japan
ID NLM: 101303952

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 25 04 2018
accepted: 07 01 2019
pubmed: 20 1 2019
medline: 30 10 2019
entrez: 20 1 2019
Statut: ppublish

Résumé

To investigate whether minimally invasive mitral valve repair (MIMVR) can be transferred from a high-volume center into a very small volume center and to clarify how many cases are necessary for maintenance of this program, early outcomes of MIMVR in Asahikawa Medical University were compared with those results in patients operated by a single surgeon in Duesseldorf University Hospital. Sixty-five patients who underwent MIMVR in Asahikawa Medical University (group A) between May 2014 and July 2018 and 134 patients who underwent MIMVR in Duesseldorf University Hospital (group D) between September 2009 and January 2014 by a surgeon who started MIMVS later in Asahikawa were retrospectively analyzed. In group D, there were more patients with ischemic mitral valve regurgitation and with annular calcification than in group A. Survival rate at 6 months and 1 year was 98.5% and 98.5% in group A and 92.9% and 91.3% in group D, respectively. EuroSCORE II was significantly higher in patients dead within 30 days and within the first year. The present study demonstrated that MIMVR programs can be transferred with acceptable early results into very low volume centers, if the team is developed by surgeons who are well trained and experienced in MIMVR. Moreover, the present study suggested that case number for maintenance of acceptable results may be obviously less than the previous recognition that this kind of specialized surgery could be maintained with at least 50 cases annually. However, meticulous preparations for surgery are essential for satisfactory surgical outcomes.

Identifiants

pubmed: 30659508
doi: 10.1007/s11748-019-01065-y
pii: 10.1007/s11748-019-01065-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

577-584

Références

Heart Lung Circ. 2003;12(3):172-7
pubmed: 16352128
J Thorac Cardiovasc Surg. 2009 Jun;137(6):1481-7
pubmed: 19464468
Eur J Cardiothorac Surg. 2012 Sep;42(3):500-6
pubmed: 22427391
Innovations (Phila). 2011 Mar;6(2):66-76
pubmed: 22437890
J Interv Cardiol. 2012 Dec;25(6):557-64
pubmed: 22861054
Circulation. 2013 Jul 30;128(5):483-91
pubmed: 23804253
Ann Cardiothorac Surg. 2013 Nov;2(6):744-50
pubmed: 24349976
Ann Cardiothorac Surg. 2013 Nov;2(6):774-8
pubmed: 24349981
Interact Cardiovasc Thorac Surg. 2015 Mar;20(3):351-8
pubmed: 25422277
Ann Cardiothorac Surg. 2015 Mar;4(2):178-81
pubmed: 25870815
Surg Today. 2015 Sep;45(9):1144-52
pubmed: 26112649
Interact Cardiovasc Thorac Surg. 2016 Jan;22(1):1-4
pubmed: 26451000
Gen Thorac Cardiovasc Surg. 2016 Nov;64(11):665-697
pubmed: 27590348
Gen Thorac Cardiovasc Surg. 2016 Dec;64(12):699-706
pubmed: 27638268
Thorac Cardiovasc Surg. 2017 Oct;65(7):505-518
pubmed: 28905340
J Thorac Cardiovasc Surg. 1998 Apr;115(4):772-9
pubmed: 9576209

Auteurs

Hiroyuki Kamiya (H)

Department of Cardiac Surgery, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan. kamiya@asahikawa-med.ac.jp.

Hiroto Kitahara (H)

Department of Cardiac Surgery, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.

Hirotsugu Kanda (H)

Department of Anesthesiology and Critical Care Medicine, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.

Hayato Ise (H)

Department of Cardiac Surgery, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.

Sentaro Nakanishi (S)

Department of Cardiac Surgery, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.

Natsuya Ishikawa (N)

Department of Cardiac Surgery, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.

Takayuki Kunisawa (T)

Department of Anesthesiology and Critical Care Medicine, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.

Jan-Philipp Minol (JP)

Department of Cardiovascular Surgery, Duesseldorf University, Moorenstrasse 5, 40225, Duesseldorf, Germany.

Artur Lichtenberg (A)

Department of Cardiovascular Surgery, Duesseldorf University, Moorenstrasse 5, 40225, Duesseldorf, Germany.

Payam Akhyari (P)

Department of Cardiovascular Surgery, Duesseldorf University, Moorenstrasse 5, 40225, Duesseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH